1. Home
  2. ANY vs XTLB Comparison

ANY vs XTLB Comparison

Compare ANY & XTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANY
  • XTLB
  • Stock Information
  • Founded
  • ANY N/A
  • XTLB 1993
  • Country
  • ANY United States
  • XTLB Israel
  • Employees
  • ANY N/A
  • XTLB N/A
  • Industry
  • ANY Finance: Consumer Services
  • XTLB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANY Finance
  • XTLB Health Care
  • Exchange
  • ANY Nasdaq
  • XTLB Nasdaq
  • Market Cap
  • ANY 14.7M
  • XTLB 12.8M
  • IPO Year
  • ANY N/A
  • XTLB 2005
  • Fundamental
  • Price
  • ANY $0.87
  • XTLB $2.18
  • Analyst Decision
  • ANY Strong Buy
  • XTLB
  • Analyst Count
  • ANY 1
  • XTLB 0
  • Target Price
  • ANY $3.00
  • XTLB N/A
  • AVG Volume (30 Days)
  • ANY 236.9K
  • XTLB 5.5K
  • Earning Date
  • ANY 11-11-2024
  • XTLB 11-20-2024
  • Dividend Yield
  • ANY N/A
  • XTLB N/A
  • EPS Growth
  • ANY N/A
  • XTLB N/A
  • EPS
  • ANY N/A
  • XTLB N/A
  • Revenue
  • ANY $25,026,000.00
  • XTLB N/A
  • Revenue This Year
  • ANY N/A
  • XTLB N/A
  • Revenue Next Year
  • ANY N/A
  • XTLB N/A
  • P/E Ratio
  • ANY N/A
  • XTLB N/A
  • Revenue Growth
  • ANY 121.94
  • XTLB N/A
  • 52 Week Low
  • ANY $0.57
  • XTLB $0.75
  • 52 Week High
  • ANY $4.09
  • XTLB $4.99
  • Technical
  • Relative Strength Index (RSI)
  • ANY 47.11
  • XTLB 32.32
  • Support Level
  • ANY $0.83
  • XTLB $2.25
  • Resistance Level
  • ANY $0.91
  • XTLB $2.56
  • Average True Range (ATR)
  • ANY 0.06
  • XTLB 0.10
  • MACD
  • ANY -0.00
  • XTLB -0.02
  • Stochastic Oscillator
  • ANY 17.13
  • XTLB 6.82

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About XTLB XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

Share on Social Networks: